OMB Reviewing FDA’s Proposed Rule To Amend ‘Intended Use’ Definition

By Beth Wang / July 30, 2020 at 6:07 PM
The White House budget office is reviewing an FDA proposed rule that clarifies what kind of evidence the agency will consider when determining a product’s intended use. FDA attempted to amend the definition three years ago by tucking the changes into a larger tobacco rule, but it then nixed the move after receiving pushback from Republican lawmakers and industry stakeholders. FDA sent its notice of proposed rulemaking, “Amendments to ‘Intended Use’ Regulations,” to the White House Office of Management and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.